Patrick Harrington

14PUBLICATIONS
40CO-AUTHORS
Molecular targetsHaematological tumoursMedical molecular engineering of nucleic acids and proteinsChiropracticEpidemiological modelling
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (14)

|Aug 15, 2026
Janus kinase inhibitors after ruxolitinib failure in myelofibrosis: A systematic review and pooled analysis of phase 3 efficacy and integrated safety across clinical trials and real-world evidence.

|Mar 28, 2026
Myeloproliferative neoplasms with concomitant chronic myeloid leukemia are associated with TKI resistance and poor outcomes.

Laura Li Gagnon, Andrea Duminuco, Fabio Stagno

|Feb 27, 2026
Integrating Genomic and Clinical Data in AML: Real-World Application of the Sanger Multistage Model.

Andrea Duminuco, Silvia Rita Vitale, Antonella Nardo

|Aug 28, 2025
Old Therapy, New Questions: Rethinking Phlebotomy in a Pharmacologic Landscape.

Andrea Duminuco, Patrick Harrington, Vittorio Del Fabro

|Jul 24, 2025
QRISK3 score is predictive of thrombotic risk in patients with myeloproliferative neoplasms.

Andrea Duminuco, Raj Vaghela, Sukhraj Virdee

|May 03, 2025
Emerging Therapeutic Approaches for Anemia in Myelofibrosis.

Helen T Chifotides, Andrea Duminuco, Elena Torre

Pageof 3

Frequent Collaborators

6 joint publications

Donal P McLornan

6 joint publications

Andrea Duminuco

5 joint publications

Claire N Harrison

5 joint publications

Giuseppe Alberto Palumbo